Plain-English translation of NCT04725617 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether improving sleep quality can help people living with HIV quit smoking more effectively. All participants will receive standard smoking cessation counseling and tartrate (a medication that reduces nicotine cravings), plus one of two behavioral health approaches designed to address sleep and other factors that affect quitting success.
People living with HIV who smoke have much higher rates of serious health problems, including heart disease. Current smoking cessation programs don't work well enough for this group. Poor sleep is common in both smokers and people with HIV, and it makes quitting harder and increases heart disease risk. This trial is testing whether treating sleep problems alongside the medication can help more people successfully quit smoking.
You likely qualify if…
You likely don't qualify if…
You will attend 8 counseling sessions over 13 weeks at the University of Arizona's research center, where you'll work with a clinical psychologist and receive the medication tartrate. You'll be assigned to one of two behavioral health approaches designed to support both sleep and smoking cessation. The study includes an overnight sleep test at the beginning to make sure you're a good fit, plus follow-up visits to check your progress at the end of treatment (13 weeks) and again at 6 months.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States